Perimeter Medical Imaging AI, Inc. (TSX-V:PINK) (OTC:PYNKF) (FSE:4PC) (“Perimeter” or the “Company”), a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address high unmet medical needs, is pleased to announce today that it has been named as one of the 2022 Venture 50 Companies by the TSX Venture Exchange. Perimeter was the sixth-ranked company in the clean tech & life science sector with a market cap increase of approximately 79% and a share price increase of 55% in 2021.
Jeremy Sobotta, Perimeter’s Chief Executive Officer stated, “We are honored to be named as one of the Venture 50 Companies and see this recognition as further validation of the significant progress made in both the commercial and clinical development areas of our business in 2021. Our TSX Venture listing has provided Perimeter with increased awareness from both the capital and commercial markets, access to capital, and additional support to drive our business forward.”
Each year, 10 companies are selected from five key sectors, based on their performance across three equally weighted criteria – market cap growth, share price appreciation, and trading and liquidity. The TSX Venture 50 program shines a light on their successes and contributions to driving growth in the Canadian economy, creating jobs, and building shareholder value.
A video showcasing Perimeter’s ranking on the 2022 Venture 50 Companies has been posted online and is also available on the Investor section of Perimeter’s website.
Representatives from the 2022 TSX Venture 50 companies will join Loui Anastasopoulos, President, Capital Formation and Enterprise Marketing Officer, TMX Group., to virtually open the market at 9:30 a.m. ET today to celebrate this achievement. For more information on the TSX Venture 50, visit: Tsx.com/Venture50.
For more such updates and perspectives around Digital Innovation, IoT, Data Infrastructure, AI & Cybersecurity, go to AI-Techpark.com.
